| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 5, 2048-2056, Copyright © 1995 by American Society of Nephrology
REVIEWS |
GM Fick, AM Johnson, WS Hammond and PA Gabow
University of Colorado Health Sciences Center, Denver 80262, USA.
To determine the causes of death in autosomal dominant polycystic kidney disease (ADPKD) patients and to examine whether the extrarenal manifestations of ADPKD influence the causes of death, the medical records of 129 patients who died between 1956 and 1993 were reviewed; 58% of the 129 patients had an autopsy performed. Seventy-seven percent died after reaching ESRD. The mean age at death increased from 51 yr for those who died before 1975 to 59 yr for those who died after 1975, reflecting the introduction of renal replacement therapies. The most common cause of death before 1975 was infection (30%), followed by uremia (28%) and cardiac disease (21%); after 1975, these were cardiac disease (36%) and infection (24%). Infection was equally prevalent before and after 1975, presenting as sepsis in 94% and directly relating to ADPKD in 47% of these patients. Underlying factors for cardiac death were cardiac hypertrophy, seen in 89% of all autopsied patients, and coronary artery disease, seen in 81%. A neurologic event was the cause of death in 12% of patients; these were ruptured intracranial aneurysm in 6%, hypertensive intracranial hemorrhage in 5%, and ischemic stroke in 1%. The mean age of those who died of ruptured intracranial aneurysm was 37 yr. No patient died of renal cancer. Liver cysts were the most common extrarenal manifestation, seen in 70% of the autopsied cases; cysts in other organs were very rare. Colonic diverticula were found in 21%. Thus, the renal and extrarenal manifestations of ADPKD are important contributors to morbidity and mortality.
This article has been cited by other articles:
![]() |
K. Turkmen, H. Oflaz, B. Uslu, A. O. Cimen, A. Elitok, E. Kasikcioglu, S. Alisir, F. Tufan, S. Namli, M. Uysal, et al. Coronary Flow Velocity Reserve and Carotid Intima Media Thickness in Patients with Autosomal Dominant Polycystic Kidney Disease: From Impaired Tubules to Impaired Carotid and Coronary Arteries Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 986 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Garcia-Gonzalez, L. F. Menezes, K. B. Piontek, J. Kaimori, D. L. Huso, T. Watnick, L. F. Onuchic, L. M. Guay-Woodford, and G. G. Germino Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway Hum. Mol. Genet., August 15, 2007; 16(16): 1940 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R Lawson, T. W Doulton, and G. A MacGregor Review: Autosomal Dominant Polycystic Kidney Disease: Role of the Renin-Angiotensin System in Raised Blood Pressure in Progression of Renal and Cardiovascular Disease Journal of Renin-Angiotensin-Aldosterone System, September 1, 2006; 7(3): 139 - 145. [Abstract] [PDF] |
||||
![]() |
J. R. Davenport and B. K. Yoder An incredible decade for the primary cilium: a look at a once-forgotten organelle Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1159 - F1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Cano, N. S. Murcia, G. J. Pazour, and M. Hebrok orpk mouse model of polycystic kidney disease reveals essential role of primary cilia in pancreatic tissue organization Development, July 15, 2004; 131(14): 3457 - 3467. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Schrier, M. M. Belz, A. M. Johnson, W. D. Kaehny, R. L. Hughes, D. Rubinstein, and P. A. Gabow Repeat Imaging for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease with Initially Negative Studies: A Prospective Ten-Year Follow-up J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1023 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Qian, M. Li, Y. Cai, C. J. Ward, S. Somlo, P. C. Harris, and V. E. Torres Analysis of the Polycystins in Aortic Vascular Smooth Muscle Cells J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2280 - 2287. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schrier, K. McFann, A. Johnson, A. Chapman, C. Edelstein, G. Brosnahan, T. Ecder, and L. Tison Cardiac and Renal Effects of Standard Versus Rigorous Blood Pressure Control in Autosomal-Dominant Polycystic Kidney Disease: Results of a Seven-Year Prospective Randomized Study J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1733 - 1739. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. ECDER and R. W. SCHRIER Hypertension in Autosomal-Dominant Polycystic Kidney Disease: Early Occurrence and Unique Aspects J. Am. Soc. Nephrol., January 1, 2001; 12(1): 194 - 200. [Full Text] |
||||
![]() |
K. Demetriou, C. Tziakouri, K. Anninou, A. Eleftheriou, M. Koptides, A. Nicolaou, C. C. Deltas, and A. Pierides Autosomal dominant polycystic kidney disease--type 2. Ultrasound, genetic and clinical correlations Nephrol. Dial. Transplant., February 1, 2000; 15(2): 205 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mariani, M. G. Bianchetti, G. Schroth, and R. W. Seiler Cerebral aneurysms in patients with autosomal dominant polycystic kidney disease—to screen, to clip, to coil? Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2319 - 2322. [Full Text] [PDF] |
||||
![]() |
D Malka, P Hammel, V Vilgrain, J-F Flejou, J Belghiti, and P Bernades Chronic obstructive pancreatitis due to a pancreatic cyst in a patient with autosomal dominant polycystic kidney disease Gut, January 1, 1998; 42(1): 131 - 134. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673